Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1
- 1 March 2017
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 232 (3) , 535-546
Abstract
Female transgenic mice that overexpress the human chorionic gonadotrophin β subunit (hCGβ+) develop prolactinomas, whereas hCGβ+ males do not. The high levels of circulating hCG induce massive luteinization in the ovary of hCGβ+ females, and progesterone becomes the primary steroid hormone produced, but estradiol remains at physiological level. The involvement of high levels of progesterone in lactotroph proliferation is not clearly understood; hence, the pathogenesis of prolactinomas in hCGβ+ females remains unclear. TGFβ1 is an inhibitor of lactotroph function, and the reduced TGFβ1 activity found in prolactinomas has been proposed to be involved in tumor development. The aim of the present work was to study the role of TGFβ1 in the gender-specific development of prolactinomas in hCGβ+ mice. We compared the expression of different components of the pituitary TGFβ1 system in males and females in this model. We found reduced TGFβ1 levels, reduced expression of TGFβ1 target genes, TGFβ1 receptors,Ltbp1,Smad4andSmad7in hCGβ+ female pituitaries. However, no differences were found between the transgenic and wild-type male pituitaries. We postulate that decreased pituitary TGFβ1 activity in hCGβ+ females is involved in the development of prolactinomas. In fact, we demonstrated that anin vivotreatment carried out for increasing pituitary TGFβ1 activity, was successful in reducing the prolactinoma development, and the hyperprolactinemia in hCGβ+ females. Moreover, the stronger TGFβ1 system found in males could protect them from excessive lactotroph proliferation. Sex differences in the regulation of the pituitary TGFβ1 system could explain gender differences in the incidence of prolactinoma.Keywords
This publication has 42 references indexed in Scilit:
- Short-Term Pharmacological Suppression of the Hyperprolactinemia of Infertile hCG-Overproducing Female Mice Persistently Restores Their FertilityEndocrinology, 2012
- Active and Total Transforming Growth Factor-β1 Are Differentially Regulated by Dopamine and Estradiol in the PituitaryEndocrinology, 2011
- Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levelsEndocrine-Related Cancer, 2010
- Silencing of the Transforming Growth Factor-β (TGFβ) Receptor II by Krüppel-like Factor 14 Underscores the Importance of a Negative Feedback Mechanism in TGFβ SignalingJournal of Biological Chemistry, 2009
- Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic miceOncogene, 2005
- Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth: Design, Synthesis, and Optimization of Pharmacokinetics and Biological ActivitiesJournal of Medicinal Chemistry, 2005
- Opposing Actions of Two Transforming Growth Factor- Isoforms on Pituitary Lactotropic Cell ProliferationEndocrinology, 2000
- Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.Journal of Histochemistry & Cytochemistry, 1996
- Progesterone Reverses the Estradiol-lnduced Decrease in Tyrosine Hydroxylase mRNA Levels in the Arcuate NucleusNeuroendocrinology, 1993
- Transforming growth factor-beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growthMolecular Endocrinology, 1992